CALP2
CAS No. 261969-04-4
CALP2 ( —— )
产品货号. M30702 CAS No. 261969-04-4
Cell-permeable calmodulin (CaM) antagonist that binds to the EF-hand/Ca2+-binding site. CALP2 has been demonstrated to inhibit CaM-dependant phosphodiesterase activity and increase intracellular Ca2+ concentrations by modulating Ca2+-channel activity. CALP2 has also been shown to be a potent activator of alveolar macrophages.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CALP2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cell-permeable calmodulin (CaM) antagonist that binds to the EF-hand/Ca2+-binding site. CALP2 has been demonstrated to inhibit CaM-dependant phosphodiesterase activity and increase intracellular Ca2+ concentrations by modulating Ca2+-channel activity. CALP2 has also been shown to be a potent activator of alveolar macrophages.
-
产品描述Cell-permeable calmodulin (CaM) antagonist that binds to the EF-hand/Ca2+-binding site. CALP2 has been demonstrated to inhibit CaM-dependant phosphodiesterase activity and increase intracellular Ca2+ concentrations by modulating Ca2+-channel activity. CALP2 has also been shown to be a potent activator of alveolar macrophages.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number261969-04-4
-
分子量1357.72
-
分子式C68H104N14O13S
-
纯度>98% (HPLC)
-
溶解度water:1 mg/mL
-
SMILES[H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Houtman et al (2001) Attenuation of very late antigen-5-mediated adhesion of bone marrow-derived mast cells to fibronectin by peptides with inverted hydropathy to EF-hands. J.Immunol. 166 861 PMID:
产品手册
关联产品
-
Acetyl-(Tyr1,D-Phe2)...
Acetyl-(Tyr1,D-Phe2)-GRF (1-29) amide (human)
-
alpha-Spinsterhood a...
alpha-Spinasterol has a significant therapeutic potential to modulate the development and/or progression of diabetic nephropathy.
-
Bavituximab
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) 是一种磷脂酰丝氨酸 (PS) 靶向的单克隆抗体,能够作用肿瘤血管系统和重新激活抗肿瘤免疫来抑制肿瘤生长。Bavituximab 联合Paclitaxel (HY-B0015) 和 Carboplatin (HY-17393),对非小细胞肺癌的抑制有加强效果。
021-51111890
购物车()
sales@molnova.cn

